In a previous study, CSF concentrations of Aβ1–42 as well as the pro-inflammatory protein S100A9 (MRP14) were decreased in AD patients and in the post-mortem brain, immunohistochemical analyses showed intense co-localized immunostaining of S100A9 and Aβ [51]. The gene discussed is S100A9; the disease is Alzheimer disease.